Patent details

EP1778239 Title: ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME

Basic Information

Publication number:
EP1778239
PCT Application Number:
PCT/IL/2005/000762
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057621450
PCT Publication Number:
WO/2006/011130
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME
French Title of Invention:
AGONISTES DU RECEPTEUR DE L'ADENOSINE A3 POUR LE TRAITEMENT DE TROUBLES DE L'OEIL SEC TELS QUE LE SYNDROME DE SJOGREN
German Title of Invention:
ADENOSIN-A3-REZEPTORAGONISTEN ZUR BEHANDLUNG VON TROCKENEM AUGE, EINSCHLIESSLICH SJÖGREN-SYNDROM
SPC Number:

Dates

Filing date:
18/07/2005
Grant date:
21/08/2013
EP Publication Date:
21/08/2013
PCT Publication Date:
02/02/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/05/2007
EP B1 Publication Date:
21/08/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/07/2014
Expiration date:
18/07/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/07/2005
 
 

Name:
Can-Fite Biopharma Ltd.
Address:
10 Bareket Street, 49170 Petach Tikva, Israel (IL)

Inventor

1

Name:
COHN Ilan
Address:
Israel (IL)

2

Name:
REITBLAT Tatiana
Address:
Israel (IL)

3

Name:
LORBER Ilana
Address:
Israel (IL)

4

Name:
FISHMAN Pnina
Address:
Israel (IL)

Priority

Priority Number:
591628 P
Priority Date:
28/07/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/52;
Filing date Document type Number of pages